Clinical Trial Update: CARBON: UAB Cardiovascular Research Biobank

View source ↗

Summary

A University of Alabama at Birmingham biobank-based clinical trial (CARBON) is currently recruiting to study natriuretic peptides in cardiovascular diseases, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Diabetes Mellitus
• Hypertension
• Obesity

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Natriuretic Peptides, Cardiovascular Diseases | Status: RECRUITING